Telo Genomics Corp. (FRA:3D0A)

Telo Genomics Balance Sheet

Financials in millions CAD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	0.49	0.79	0.8	2.67	2.69	3.64
Cash & Short-Term Investments	0.49	0.79	0.8	2.67	2.69	3.64
Cash Growth	48.20%	-0.84%	-70.22%	-0.73%	-25.95%	294.85%
Other Receivables	0.02	0.03	0.03	0.06	0.04	0.1
Receivables	0.02	0.03	0.03	0.06	0.04	0.1
Prepaid Expenses	0.09	0.08	0.09	0.11	0.06	0.03
Total Current Assets	0.59	0.89	0.92	2.84	2.79	3.76
Property, Plant & Equipment	0.01	0	0.01	0.04	0.02	-
Other Intangible Assets	0.01	0.01	0.04	0.04	0.02	0.08
Total Assets	0.61	0.91	0.97	2.93	2.83	3.84
Accounts Payable	0.52	0.33	0.27	0.15	0.19	0.1
Accrued Expenses	0.12	0.07	0.11	0.13	0	0.01
Current Portion of Long-Term Debt	-	-	-	0.03	-	-
Total Current Liabilities	0.63	0.4	0.38	0.31	0.19	0.11
Long-Term Debt	-	-	-	-	0.04	0.04
Total Liabilities	0.63	0.4	0.38	0.31	0.23	0.15
Common Stock	24.62	24.57	22.35	21.69	19.11	18.23
Additional Paid-In Capital	6.44	6.44	6.07	6	5.79	5.64
Retained Earnings	-31.09	-30.55	-27.83	-25.12	-22.3	-20.19
Comprehensive Income & Other	-	0.05	-	0.04	-	-
Shareholders' Equity	-0.03	0.51	0.59	2.61	2.6	3.69
Total Liabilities & Equity	0.61	0.91	0.97	2.93	2.83	3.84
Total Debt	-	-	-	0.03	0.04	0.04
Net Cash (Debt)	0.49	0.79	0.8	2.64	2.65	3.6
Net Cash Growth	48.20%	-0.84%	-69.86%	-0.46%	-26.24%	308.24%
Net Cash Per Share	0.01	0.01	0.01	0.04	0.05	0.08
Filing Date Shares Outstanding	100.43	100.43	74.56	71.31	59.42	57.49
Total Common Shares Outstanding	100.43	100.02	74.56	71.16	59.42	55.54
Working Capital	-0.05	0.5	0.54	2.53	2.6	3.65
Book Value Per Share	-0.00	0.01	0.01	0.04	0.04	0.07
Tangible Book Value	-0.04	0.5	0.55	2.57	2.58	3.61
Tangible Book Value Per Share	-0.00	0.01	0.01	0.04	0.04	0.06
Machinery	0.15	0.15	0.14	0.14	0.1	0.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.